CN105112407B - A kind of kit and its application for being used to detect enterovirus - Google Patents
A kind of kit and its application for being used to detect enterovirus Download PDFInfo
- Publication number
- CN105112407B CN105112407B CN201510479314.9A CN201510479314A CN105112407B CN 105112407 B CN105112407 B CN 105112407B CN 201510479314 A CN201510479314 A CN 201510479314A CN 105112407 B CN105112407 B CN 105112407B
- Authority
- CN
- China
- Prior art keywords
- sequence
- probe
- primer pair
- enterovirus
- kit
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 241000709661 Enterovirus Species 0.000 title claims abstract description 62
- 239000000523 sample Substances 0.000 claims description 77
- 230000003321 amplification Effects 0.000 claims description 52
- 238000003199 nucleic acid amplification method Methods 0.000 claims description 52
- 108020004414 DNA Proteins 0.000 claims description 48
- 102000053602 DNA Human genes 0.000 claims description 45
- 238000006243 chemical reaction Methods 0.000 claims description 45
- 239000000243 solution Substances 0.000 claims description 22
- 102000004190 Enzymes Human genes 0.000 claims description 12
- 108090000790 Enzymes Proteins 0.000 claims description 12
- 108091032973 (ribonucleotides)n+m Proteins 0.000 claims description 11
- 108020004682 Single-Stranded DNA Proteins 0.000 claims description 11
- 239000000203 mixture Substances 0.000 claims description 11
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 11
- 239000007853 buffer solution Substances 0.000 claims description 10
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 claims description 9
- 239000013642 negative control Substances 0.000 claims description 7
- 102100034343 Integrase Human genes 0.000 claims description 6
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 claims description 6
- 239000002904 solvent Substances 0.000 claims description 6
- ABZLKHKQJHEPAX-UHFFFAOYSA-N tetramethylrhodamine Chemical compound C=12C=CC(N(C)C)=CC2=[O+]C2=CC(N(C)C)=CC=C2C=1C1=CC=CC=C1C([O-])=O ABZLKHKQJHEPAX-UHFFFAOYSA-N 0.000 claims description 5
- 108091028733 RNTP Proteins 0.000 claims description 4
- 238000010791 quenching Methods 0.000 claims description 4
- 230000000171 quenching effect Effects 0.000 claims description 4
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 claims description 3
- 101710203526 Integrase Proteins 0.000 claims description 3
- OKIZCWYLBDKLSU-UHFFFAOYSA-M N,N,N-Trimethylmethanaminium chloride Chemical class [Cl-].C[N+](C)(C)C OKIZCWYLBDKLSU-UHFFFAOYSA-M 0.000 claims description 3
- 102000009609 Pyrophosphatases Human genes 0.000 claims description 3
- 108010009413 Pyrophosphatases Proteins 0.000 claims description 3
- 108010092799 RNA-directed DNA polymerase Proteins 0.000 claims description 3
- 229910001629 magnesium chloride Inorganic materials 0.000 claims description 3
- 239000003161 ribonuclease inhibitor Substances 0.000 claims description 3
- 125000006853 reporter group Chemical group 0.000 claims description 2
- 230000003287 optical effect Effects 0.000 claims 1
- 238000001514 detection method Methods 0.000 abstract description 18
- 238000000034 method Methods 0.000 abstract description 15
- 238000012360 testing method Methods 0.000 abstract description 15
- 238000012544 monitoring process Methods 0.000 abstract description 7
- 206010014909 Enterovirus infection Diseases 0.000 abstract description 6
- 239000003814 drug Substances 0.000 abstract description 3
- 229940079593 drug Drugs 0.000 abstract description 2
- 230000004907 flux Effects 0.000 abstract description 2
- 238000001179 sorption measurement Methods 0.000 description 26
- 239000013612 plasmid Substances 0.000 description 18
- 108090000623 proteins and genes Proteins 0.000 description 14
- 150000007523 nucleic acids Chemical class 0.000 description 10
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 9
- 238000005119 centrifugation Methods 0.000 description 9
- 102000039446 nucleic acids Human genes 0.000 description 9
- 108020004707 nucleic acids Proteins 0.000 description 9
- 238000003757 reverse transcription PCR Methods 0.000 description 9
- 201000010099 disease Diseases 0.000 description 6
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 6
- 239000011259 mixed solution Substances 0.000 description 6
- 230000035945 sensitivity Effects 0.000 description 6
- 238000013518 transcription Methods 0.000 description 6
- 230000035897 transcription Effects 0.000 description 6
- 238000005516 engineering process Methods 0.000 description 5
- 239000007788 liquid Substances 0.000 description 5
- 229920000936 Agarose Polymers 0.000 description 4
- 239000013614 RNA sample Substances 0.000 description 4
- 241000700605 Viruses Species 0.000 description 4
- 230000009514 concussion Effects 0.000 description 4
- 238000002156 mixing Methods 0.000 description 4
- 239000002773 nucleotide Substances 0.000 description 4
- 125000003729 nucleotide group Chemical group 0.000 description 4
- 238000004806 packaging method and process Methods 0.000 description 4
- 238000002360 preparation method Methods 0.000 description 4
- 239000012925 reference material Substances 0.000 description 4
- 108700039887 Essential Genes Proteins 0.000 description 3
- 102100031181 Glyceraldehyde-3-phosphate dehydrogenase Human genes 0.000 description 3
- 208000020061 Hand, Foot and Mouth Disease Diseases 0.000 description 3
- 101000702488 Rattus norvegicus High affinity cationic amino acid transporter 1 Proteins 0.000 description 3
- 239000000969 carrier Substances 0.000 description 3
- 238000010367 cloning Methods 0.000 description 3
- 230000029087 digestion Effects 0.000 description 3
- 238000010790 dilution Methods 0.000 description 3
- 239000012895 dilution Substances 0.000 description 3
- 238000010828 elution Methods 0.000 description 3
- 108020004445 glyceraldehyde-3-phosphate dehydrogenase Proteins 0.000 description 3
- 238000011901 isothermal amplification Methods 0.000 description 3
- 239000006210 lotion Substances 0.000 description 3
- 239000012488 sample solution Substances 0.000 description 3
- 230000003612 virological effect Effects 0.000 description 3
- 238000005406 washing Methods 0.000 description 3
- 241000709687 Coxsackievirus Species 0.000 description 2
- 208000025713 Hand-foot-and-mouth disease Diseases 0.000 description 2
- 102000006382 Ribonucleases Human genes 0.000 description 2
- 108010083644 Ribonucleases Proteins 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 239000000872 buffer Substances 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- 238000005538 encapsulation Methods 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 108020004999 messenger RNA Proteins 0.000 description 2
- 239000002504 physiological saline solution Substances 0.000 description 2
- 239000002574 poison Substances 0.000 description 2
- 231100000614 poison Toxicity 0.000 description 2
- 238000004080 punching Methods 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 102000040650 (ribonucleotides)n+m Human genes 0.000 description 1
- 101150072531 10 gene Proteins 0.000 description 1
- 208000035473 Communicable disease Diseases 0.000 description 1
- 238000002965 ELISA Methods 0.000 description 1
- 241001466953 Echovirus Species 0.000 description 1
- 241000988559 Enterovirus A Species 0.000 description 1
- 241000991587 Enterovirus C Species 0.000 description 1
- 241000798443 Hornodermoporus martius Species 0.000 description 1
- 208000009525 Myocarditis Diseases 0.000 description 1
- 108091028043 Nucleic acid sequence Proteins 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 208000033952 Paralysis flaccid Diseases 0.000 description 1
- 101710137500 T7 RNA polymerase Proteins 0.000 description 1
- 108020000999 Viral RNA Proteins 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000000692 anti-sense effect Effects 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 208000002352 blister Diseases 0.000 description 1
- 210000003169 central nervous system Anatomy 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000001079 digestive effect Effects 0.000 description 1
- 238000013399 early diagnosis Methods 0.000 description 1
- 206010014599 encephalitis Diseases 0.000 description 1
- 210000001842 enterocyte Anatomy 0.000 description 1
- 239000002532 enzyme inhibitor Substances 0.000 description 1
- 229940125532 enzyme inhibitor Drugs 0.000 description 1
- 208000028331 flaccid paralysis Diseases 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000001404 mediated effect Effects 0.000 description 1
- 210000000214 mouth Anatomy 0.000 description 1
- 208000030194 mouth disease Diseases 0.000 description 1
- 239000002777 nucleoside Substances 0.000 description 1
- 125000003835 nucleoside group Chemical group 0.000 description 1
- 238000004393 prognosis Methods 0.000 description 1
- 230000036632 reaction speed Effects 0.000 description 1
- 238000003753 real-time PCR Methods 0.000 description 1
- 210000002345 respiratory system Anatomy 0.000 description 1
- 108091008146 restriction endonucleases Proteins 0.000 description 1
- 229920002477 rna polymer Polymers 0.000 description 1
- 235000015170 shellfish Nutrition 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
Landscapes
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
The invention discloses a kind of kit and its application for being used to detect enterovirus.Contain the primer pair group for being used for detecting enterovirus in kit provided by the present invention, be made up of 3 primer pairs, its sequence is sequence 16 in sequence table.Kit provided by the invention supports high flux, common enterovirus infection can quickly and accurately be detected, for clinic, the testing result that 3 kinds of enterovirus indexs can be obtained in 1 hour is not only faster than the real time fluorescence quantifying PCR method more generally used at present, and also significant for the treatment of quick auxiliary direction and medication.Meanwhile the detection of multi objective can be used for regional epidemiological survey and epidemic situation monitoring, to study popularity of the enterovirus infection in China.
Description
Technical field
The invention belongs to nucleic acid amplification technologies field, is related to a kind of kit and its application for being used to detect enterovirus.
Background technology
Enterovirus includes poliovirus, Coxsackie virus (Coxsackievirus), causes enterocyte lesion people
Orphan virus (enterocytopathichumanorphanvirusECHO abbreviations echovirus) and newtype enteroviru totally 71
Individual serotype.Infectious disease caused by enterovirus genus virus, clinical manifestation the lighter only have Juan Dai ﹑ Fa Li ﹑ low-heat etc., and severe one can be complete
The vitals such as body infection , Nao ﹑ Ji Sui ﹑ Xin ﹑ livers are damaged, and prognosis is poor, and can leave sequelae or cause death.This class disease
It is distributed in all over the world, has in Perenniporia martius whole year, summer is common in temperate zone, Wen Nuan ﹑ Chao Shi ﹑ sanitary condition Cha ﹑
The crowded regional incidence of disease is high.
Hand-foot-and-mouth disease (Hand-foot-mouth disease, HFMD) is the clinical disease as caused by enterovirus infection
Group, has the characteristics of diverse clinical manifestations, and majority of cases clinical manifestation is lighter, with the fash at the positions such as heating and hand, foot, oral cavity
Or bleb is principal character.There is respiratory system, central nervous system damage in a small number of cases, cause encephalitis, myocarditis, edema with the lung involved
The symptoms such as swollen, flaccid paralysis, indivedual children with serious disease rapid onsets, cause death.Triggering the enterovirus of hand-foot-and-mouth disease has more than 20
Kind, including Coxsackie virus A group, enterovirns type 71 etc..
Rapid＆Early diagnosis enterovirus infection can guiding clinical treatment be in time reasonable selection antiviral antibacterial medicine
Thing offer foundation is simultaneously significant in terms of abuse of antibiotics is prevented.
The method for detecting common enterovirus at present is more, but all Shortcomings, such as Electronic Speculum detection method complex and expensive, disease
Poison is separately cultured time-consuming extremely length and false negative is more, and generally clinical meaning, ELISA have been lost after cultivation results are taken
Detection is special viral antibody but is once only capable of detecting a kind of virus.And the detection of nucleic acids based on nucleic acid amplification, due to speed
Degree fast (can complete to detect in usual 3 hours), high sensitivity, specificity are good, and goldstandard is increasingly becoming in field of virus detection.
The amplification technique (Nucleic Acid Sequence Based Amplification) of nucleotide sequence is relied on, i.e.,
NASBA amplification techniques, it is to be mediated by pair of primers, be specific in vitro and continuous homogeneous to single stranded RNA progress constant temperature expansion
The process of increasing.Under 41 DEG C of constant temperatures, in terms of reaction speed, template ribonucleic acid can be expanded about 10 by NASBA amplifications 1h9~1012
Times, and common PCR reactions need 2~3h.In terms of detection sensitivity, NASBA, which can be detected, is less than 10gene in solution
Copies/ μ l trace target, and PCR test limit is in 100gene copies/ μ l or so.Therefore, NASBA technologies are either
Amplification efficiency or detection sensitivity are all higher than RT-PCR technology.And because NASBA reaction only needs one 41 DEG C of perseverance
Warm condition, water-bath can meet that reaction requires, it is not necessary to the temperature control device that the Standard PCR such as complicated heating and cooling is relied on, because
The instrument cost of this NASBA technology is very cheap.Combined with corresponding detection technique, NASBA also has easy to operate, specific
Many advantages, such as strong.
The content of the invention
First purpose of the present invention is to provide a kind of primer pair group for being used to detect enterovirus.
The primer pair group provided by the present invention for being used to detect enterovirus, is made up of following 3 primer pairs：
The primer pair 1 being made up of two single strand dnas shown in sequence in sequence table 1 and sequence 2；By sequence in sequence table
The primer pair 2 of two single strand dnas composition shown in row 3 and sequence 4；As two shown in sequence in sequence table 5 and sequence 6
The primer pair 3 of single strand dna composition.
Wherein, the primer pair 1 (Entv_TY) is used to expand enterovirus；The primer pair 2 (EV71_VP1) is used to expand
Increase enterovirus EV 71 type；The primer pair 3 (CA16_VP1) is used to expand enterovirus CA16 types.
Second object of the present invention is to provide a kind of complete single stranded DNA for being used to detect enterovirus.
The complete single stranded DNA provided by the present invention for being used to detect enterovirus, by probe groups and the primer pair group group
Into；The probe groups are made up of following 3 ssDNA probes：SsDNA probe 1 in sequence table shown in sequence 7；Sequence table
SsDNA probe 2 shown in middle sequence 8；SsDNA probe 3 in sequence table shown in sequence 9.
Wherein, the ssDNA probe 1 (Entv_TY_MB) is used for the amplification for monitoring the primer pair 1 in real time；Institute
State the amplification that ssDNA probe 2 (EV71_VP1_MB) is used to monitor the primer pair 2 in real time；The ssDNA probe 3
(CA16_VP1_MB) it is used for the amplification for monitoring the primer pair 3 in real time.
5 ' the ends mark of every ssDNA probe in the probe groups has FAM, and 3 ' ends mark
There is fluorescent quenching group TAMRA.
In the complete single stranded DNA provided by the present invention, each primer pair and its corresponding ssDNA probe can be single
Solely it is packaged in a packaging.As the primer pair 1 and the ssDNA probe 1 are packaged in first packaging；The primer
2 and the ssDNA probe 2 are packaged in second packaging；The primer pair 3 and the ssDNA probe 3 are packaged in
In three packagings.
Third object of the present invention is to provide a kind of kit for being used to detect enterovirus.
The kit provided by the present invention for being used to detect enterovirus, contains the primer pair group or described complete single-stranded
DNA。
The kit can also contain internal reference primer pair and internal reference probe.The internal reference primer pair is for expanding
House-keeping gene GAPDH mRNA primer pair GAPD_IC in human genome, as two shown in sequence in sequence table 10 and sequence 11
Bar single strand dna forms.The internal reference probe (GAPD_IC_MB) is that the single stranded DNA in sequence table shown in sequence 12 is visited
Pin, for monitoring the amplification of the internal reference primer pair (GAPD_IC) in real time.
5 ' ends of the internal reference probe are marked with fluorescent reporter group FAM, and 3 ' ends are marked with fluorescent quenching group
TAMRA。
Constant-temperature amplification buffer solution and constant-temperature amplification enzyme solutions can also be contained in the kit.
The solvent of the constant-temperature amplification buffer solution is water, and solute and concentration are as follows：200mM pH 8.0 Tris-HCL,
50mM DTT, 10mM dNTP, 10mM rNTP, 80mM MgCl2, 450mM KCl, 15% volumn concentration DMSO, 1M sorb
Alcohol, 20mM tetramethyl ammonium chlorides.
The solvent of the constant-temperature amplification enzyme solutions is water, and solute and concentration are as follows：AMV reverse transcriptase 1U/ μ l, T7RNA gather
Synthase 5U/ μ l, ribonuclease H 0.5U/ μ l, the μ g/ μ l of pyrophosphatase 0.5U/ μ l, RNase inhibitor 5U/ μ l, BSA 0.5.
Dish-style chip can also be contained in the kit, such as 24 reaction chamber dish-style chips.
In the present invention, the 24 reaction chamber dish-style chip is " the brilliant core of Capitalbio Corporation Co., Ltd.'s production
The supporting dish-style chip of RTisochipTM-A constant-temperature amplification micro-fluidic chips nucleic acids instrument ", its model 1 × 24.
The 1# of the dish-style chip deposits dry following (1)-(5) to 5# reaction chambers respectively：
(1) primer pair 1 and the ssDNA probe 1；(2) primer pair 2 and the ssDNA probe 2；(3)
The primer pair 3 and the ssDNA probe 3；(4) the internal reference primer pair and the internal reference probe；(5) negative control
Product.
The negative controls concretely water without RNase (Rnase-free water).
Wherein, the method for primer and probe being embedded into dish-style chip is：By primer, the spy corresponding with the primer
Pin, agarose mixing, are configured to mixed solution, make the primer, the probe and the agarose in the mixed solution
Final concentration be respectively 0.2 μM, 50nM, 0.1% (weight/mass percentage composition)；Mixed solution described in 1 μ l is taken to click and enter corresponding dish-style
Chip reaction chamber, after being dried in clean super-clean bench, tabletting encapsulation, punching press is made after vacuumizing.
The non-diagnostic mesh of the primer pair group or complete single stranded DNA or kit in detecting or aiding in detection enterovirus
Application fall within protection scope of the present invention.
In the application, by constant-temperature amplification enzyme solutions described in constant-temperature amplification buffer solution described in 15 μ l and 10 μ l, with 25 μ l
It is injected into after the mixing of sample to be tested solution in the dish-style chip, isothermal reaction 1h at 41 DEG C.
In the application, sample to be tested can be used as using Nasopharyngeal swabs；Accordingly, the sample to be tested solution can be from nose
The RNA extracted in throat swab.
In the present invention, the enterovirus is concretely at least one of following：Enterovirus, enterovirus EV 71
Type and enterovirus CA16 types.
Kit provided by the invention supports high flux, can quickly and accurately detect enterovirus infection, for clinical
Speech, can be obtained in 1 hour 3 kinds of enterovirus indexs testing result be not only faster than it is current more generally use it is real-time glimmering
Fluorescent Quantitative PCR method, and it is also significant for the treatment of quick auxiliary direction and medication.Meanwhile the detection of multi objective
Regional epidemiological survey and epidemic situation monitoring are can be used for, to study popularity of the enterovirus infection in China.
Brief description of the drawings
Fig. 1 is dish-style chip and primer sample application cavity schematic diagram.
Fig. 2 is 3 kinds of enterovirus reference material dish-style chip testing result figures.Wherein, A is to contain enterovirus target gene
Recombinant plasmid pUC19-Entv 1# reaction chambers testing result；B is the restructuring matter containing enterovirus EV 71 target gene
Testing results of the grain pUC19-EV71 in 2# reaction chambers；C is the recombinant plasmid pUC19- containing enterovirus CA16 target genes
Testing results of the CA16 in 3# reaction chambers.In A-C, E1 represents that template is 101Copy/μ l, by that analogy, E5 represent that template is 105
Copy/μ l；NC represents negative control.
Embodiment
Experimental method used in following embodiments is conventional method unless otherwise specified.
Material used, reagent etc., unless otherwise specified, are commercially obtained in following embodiments.
The preparation and its use of embodiment 1, kit for detecting enterovirus
First, for the preparation for the kit for detecting enterovirus
Kit forms provided by the present invention for detecting enterovirus are as follows：
1st, constant-temperature amplification buffer solution
The solvent of constant-temperature amplification buffer solution is water, and solute and concentration are as follows：200mM Tris-HCL (pH 8.0), 50mM
DTT, 10mM dNTP, 10mM rNTP, 80mM MgCl2, 450mM KCl, 15% volumn concentration DMSO, 1M sorbierite,
20mM tetramethyl ammonium chlorides.
2nd, constant-temperature amplification enzyme solutions
The solvent of constant-temperature amplification enzyme solutions is water, and solute and concentration are as follows：AMV reverse transcriptase 1U/ μ l, t7 rna polymerase
5U/ μ l, ribonuclease H 0.5U/ μ l, pyrophosphatase 0.5U/ μ l, RNase inhibitor 5U/ μ l, BSA0.5 μ g/ μ l.
3rd, 24 reaction chamber dish-style chips of primer pair and ssDNA probe are mounted with
The 24 reaction chamber dish-style chip is " the brilliant core RTisochipTM-A perseverances of Capitalbio Corporation Co., Ltd.'s production
The supporting dish-style chip of temperature amplification micro-fluidic chip nucleic acids instrument ", its model 1 × 24, schematic diagram is as shown in Figure 1.
The 1# of the 24 reaction chamber dish-style chip deposits dry following (1)-(5) to 5# reaction chambers respectively：
(1) primer pair 1 and ssDNA probe 1；(2) primer pair 2 and ssDNA probe 2；(3) primer pair 3 and single stranded DNA
Probe 3；(4) internal reference primer pair and internal reference probe；(5) negative controls.The negative controls are specially without RNase
Water (Rnase-free water).
Wherein, the primer pair 1 (Entv_TY) is used to expand enterovirus, as shown in sequence in sequence table 1 and sequence 2
Two single strand dnas composition；The primer pair 2 (EV71_VP1) is used to expand enterovirus EV 71 type, by sequence table
Two single strand dnas composition shown in sequence 3 and sequence 4；The primer pair 3 (CA16_VP1) is used to expand enterovirus
CA16 types, it is made up of two single strand dnas shown in sequence in sequence table 5 and sequence 6.Internal reference primer pair (the GAPD_
IC) it is used to expand house-keeping gene GAPDH mRNA in human genome, as two lists shown in sequence in sequence table 10 and sequence 11
Ssdna molecule forms.
The ssDNA probe 1 (Entv_TY_MB) is used for the amplification for monitoring the primer pair 1 in real time, its nucleosides
Acid sequence is sequence 7 in sequence table；The ssDNA probe 2 (EV71_VP1_MB) is used to monitor the primer pair 2 in real time
Amplification, its nucleotides sequence are classified as sequence 8 in sequence table；The ssDNA probe 3 (CA16_VP1_MB) is used to supervise in real time
The amplification of the primer pair 3 is surveyed, its nucleotides sequence is classified as sequence 9 in sequence table.Internal reference probe (the GAPD_IC_
MB) it is used for the amplification for monitoring the internal reference primer pair (GAPD_IC) in real time, its nucleotides sequence is classified as sequence in sequence table
12.5 ' the ends mark of every ssDNA probe and the internal reference probe (GAPD_IC_MB) has base
Group FAM, 3 ' ends mark have TAMRA.
Wherein, the method for primer and probe being embedded into dish-style chip is：By primer, the spy corresponding with the primer
Pin, agarose mixing, are configured to mixed solution, make the primer, the probe and the agarose in the mixed solution
Final concentration be respectively 0.2 μM, 50nM, 0.1% (weight/mass percentage composition)；Mixed solution described in 1 μ l is taken to click and enter corresponding dish-style
Chip reaction chamber, after being dried in clean super-clean bench, tabletting encapsulation, punching press is made after vacuumizing.
2nd, for the application method for the kit for detecting enterovirus
1st, reaction system is prepared
15 μ l constant-temperature amplifications buffer solutions (see step 1 1), 10 μ l constant-temperature amplifications enzyme solutions (see step 1 2), 25 μ l are taken to treat
This liquid of test sample is mixed into 50 μ l reaction solutions, after vortex concussion uniformly injection be mounted with primer pair and the 24 of ssDNA probe anti-
Chamber dish-style chip (see step 1 3) is answered, seals Quick spin 30s after membrana oralis.
2nd, isothermal amplification reactions and detection
Dish-style chip is placed in rich Isochip-RT constant-temperature amplifications instrument difficult to understand, sets 41 DEG C to react 1 hour, and complete simultaneously
Real-time fluorescence scans.
3rd, result judges
After reaction terminates, the sample to be tested liquid is determined according to the amplification curve of sample in each reaction chamber as follows
In whether contain corresponding enterovirus genome：If the testing sample produces S type amplification curves, the sample to be tested liquid
In contain corresponding enterovirus genome；Conversely, the genome of corresponding enterovirus is not contained in the sample to be tested liquid then.
Embodiment 2, the analysis of the sensitivity and specificity of kit for detecting enterovirus
First, the preparation of reference material RNA nucleic acid
1st, structure includes the plasmid of enterovirus target gene
(1) plasmid containing enterovirus target gene
By 5~1705 sections of enterovirus Entv target gene sequences (enterovirus Entv target gene sequences
Genbank Sequence ID:Gb | KC755230.1 |, Update Date：2013-12-17) be inserted into pUC19 carriers (my god
With biochemical corp's product) multiple cloning sites EcoR V between, obtain recombinant plasmid pUC19-Entv.
(2) plasmid containing enterovirus EV 71 target gene
By 4~1695 sections of enterovirus EV 71 target gene sequence (enterovirus EV 71 target gene sequence
Genbank Sequence ID:Gb | HM245928.1 |, Update Date：2011-9-27) be inserted into pUC19 carriers (my god
With biochemical corp's product) multiple cloning sites EcoR V between, obtain recombinant plasmid pUC19-EV71.
(3) plasmid containing enterovirus CA16 target genes
By 1392~2564 sections of enterovirus CA16 target gene sequences (enterovirus CA16 target gene sequences
Genbank Sequence ID:Gb | AY790926.1 |, Update Date：2005-8-9) be inserted into pUC19 carriers (day with
Biochemical corp's product) multiple cloning sites EcoR V between, obtain recombinant plasmid pUC19-CA16.
2nd, the preparation of reference material RNA nucleic acid
For trying recombinant plasmid：3 kinds of recombinant plasmids for containing corresponding enterovirus target gene that step 1 is built.
(1) digestion：First 37 DEG C of digestion 2h of EcoRI restriction endonucleases are used by each for examination recombinant plasmid.
(2) transcribe：It polymerize by 5 μ l 5 × Transcription Optimized Buffer (Promega), 2U T7RNA
Enzyme, 10mM DTT (Promega), 10U recombinant RNAs enzyme inhibitor (Promega), 2mM rNTP, the μ l of digestion products 5 prepare overall
Product is 50 μ l reaction system, 37 DEG C of transcription 4h after shaking uniformly.
(3) digest：System after the completion of transcription is added to 1 μ l DNA digestive ferments (rDnaseI, 5U/ μ l), concussion centrifuges,
37 DEG C of incubation 20min.
(4) purify：Using the RNA purification kits products of Macherey-Nage companies, (its catalog number is
740948) transcription product RNA is purified as follows：A) RA1-C is prepared2H5OH mixed liquors：With RA1:C2H5OH=1:1 (volume
Than) ratio prepare., it is necessary to add 600 μ l RA1-C in every 100 μ l transcription product2H5OH mixed liquors, i.e. 300 μ l RA1+
300μl C2H5OH solution, need to calculate the volume for matching somebody with somebody mixed liquor according to the pipe number of transcription product herein.If product is insufficient
100 μ l, then the amount of product is mended to 100 μ l with water and (50 μ l Tiangeng Rnase-free H are added in every pipe product2O)。
B) the ready RA1-C by before2H5OH mixed liquors are assigned in 1.5ml centrifuge tubes, two pipes, often the μ l of pipe 600, and 100 μ l products are turned
Enter into corresponding centrifuge tube, totally 700 μ l, fully shaking centrifuge in pipe.C) prepare two adsorption columns, and carry out corresponding mark
Note, 700 μ l product mixtures are transferred in adsorption column (adsorption column maximum capacity is 700 μ l), 1.2 ten thousand rpm centrifugation 2min, are fallen
Fall down a layer solution.D) 700 μ l RA3 is added in adsorption column, 1min is placed, it is sufficiently dispersed in the bottom of adsorption column
Portion, 1.2 ten thousand rpm centrifugation 2min, outwells lower floor's solution.E) 350 μ l RA3 is added in adsorption column, places 2min, 1.2 ten thousand rpm
2min is centrifuged, outwells lower floor's solution.F) 300 μ l RA3 is added in adsorption column, 2min is placed, 1.2 ten thousand rpm centrifugation 2min, falls
Fall down a layer solution.G) after the lid 3min for opening adsorption column, 1.2 ten thousand rpm skies outwell lower floor's solution, repeat this step from 2min
Once.H) it is empty from end after, adsorption column is transferred in corresponding centrifuge tube, opens adsorption column lid and place 15min, make
Ethanol volatilization is complete, and 60 μ l Rnase-H are added in adsorption column2O (carries) elution in kit, place 2min, and 1.2 ten thousand
Rpm centrifuges 2min.I) centrifugation gained template is sucked back in adsorption column, places 2min, 1.2 ten thousand rpm centrifugation 2min, repeat this step
Twice.J) adsorption column is lost, the template in centrifuge tube is taken out into 2 μ l, determines its concentration with Nano drop, and record its concentration
And its 260/280,260/230 ratio.
2nd, for the sensitivity and specificity analysis for the kit for detecting enterovirus
1st, prepared by the reference material template of various concentrations
It is fixed that each RNA templates (the 3 kinds of recombinant plasmids built in corresponding step 1 1) of above-mentioned steps one after purification are calculated
Measure to 1010Copy/μ l, and gradient dilution, obtain 105Copy/μ l, 104Copy/μ l, 103Copy/μ l, 102Copy/μ l, 10 are copied
The template dilution of the various concentrations such as shellfish/μ l.
2nd, reaction system is prepared
15 μ l constant-temperature amplifications buffer solutions are taken (see the step 1) of embodiment 1,10 μ l constant-temperature amplifications enzyme solutions (see the step of embodiment 1
2), the template dilution of 25 μ l concentration is mixed into 50 μ l reaction solutions, after vortex concussion uniformly injection be mounted with primer pair and
24 reaction chamber dish-style chips of ssDNA probe (see the step 3) of embodiment 1, seal Quick spin 30s after membrana oralis.
3rd, isothermal amplification reactions and detection
Dish-style chip is placed in rich Isochip-RT constant-temperature amplifications instrument difficult to understand, sets 41 DEG C to react 1 hour, and complete simultaneously
Real-time fluorescence scans.And result is judged according to the method for the step 23 of embodiment 1.
3rd, result
As a result it is as shown in Figure 2：
(1) for recombinant plasmid pUC19-Entv RNA sample, the 1# reaction chambers pair of 24 reaction chamber dish-style chips
105Copy/μ l, 104Copy/μ l, 103Copy/μ l, 102The testing result of copy/μ l, 10 copies/μ l templates has obvious S
Type amplification curve, it is shown as positive；And 2# and 3# reaction chambers are shown as negative without amplification curve.
(2) for recombinant plasmid pUC19-EV71 RNA sample, the 2# reaction chambers pair of 24 reaction chamber dish-style chips
105Copy/μ l, 104Copy/μ l, 103Copy/μ l, 102The testing result of copy/μ l, 10 copies/μ l templates has obvious S
Type amplification curve, it is shown as positive；And 1# and 3# reaction chambers are shown as negative without amplification curve.
(3) for recombinant plasmid pUC19-CA16 RNA sample, the 3# reaction chambers pair of 24 reaction chamber dish-style chips
105Copy/μ l, 104Copy/μ l, 103Copy/μ l, 102The testing result of copy/μ l, 10 copies/μ l templates has obvious S
Type amplification curve, it is shown as positive；And 1# and 2# reaction chambers are shown as negative without amplification curve.
In addition, for the RNA sample of 3 kinds of all recombinant plasmids, the 4# reaction chambers of 24 reaction chamber dish-style chips are (interior
Control) and 5# reaction chambers (negative control) without amplification curve.4# reaction chambers (internal reference) why without amplification curve be because
Sample to be tested is the RNA nucleic acid of 3 kinds of recombinant plasmids, does not contain the RNA of house-keeping gene GAPDH in human genome.
It these results suggest that the kit has higher amplification sensitivity and specific amplification.
The detection of embodiment 3, actual clinical sample
First, clinical sample type
The present embodiment use clinical sample from Shenzhen San Yuan in collection Nasopharyngeal swabs sample (in line with this picker from
The principle of hope), adopt swab and deposit in 3mL physiological saline, totally 560.
2nd, in clinical sample viral nucleic acid extraction
Clinical sample viral nucleic acid extraction kit used is QIAamp Viral RNA Mini Kit (Qiagen),
Extracted as follows：
(1) take and the μ l of physiological saline 140 of clinical sample swab are deposited in step 1 in 1.5ml centrifuge tubes；
(2) Buffer AVL (the i.e. 5.6 μ l Carrier RNA mixing that 560 μ l contain Carrier RNA mixed liquors is added
The μ l Buffer of liquid+560 AVL are in centrifuge tube, slight whirlpool 15s；
(3) after the completion of brief centrifugation, (15-25 DEG C) placement 10-20min of room temperature, to ensure Buffer AVL in centrifuge tube
In have abundance time cracked；
(4) 560 μ l ethanol (96-100%, volumn concentration) are added in centrifuge tube, whirlpool mixes 15s, centrifugation；
(5) 630 μ l sample solutions are taken in adsorption column, 2min is placed, it is fully contacted with adsorption column, 8000rpm, from
Heart 1min, change clean collecting pipe；
(6) if sample solution is more than 630 μ l, repeatedly previous step；
(7) 500 μ l AW1 washing lotions are added in adsorption column, 2min is placed, it is fully contacted with adsorption column, 8000rpm
1min is centrifuged, changes clean collecting pipe；
(8) 500 μ l AW2 washing lotions are added in adsorption column, 2min is placed, it is fully contacted with adsorption column,
12000rpm centrifuges 3min, changes clean collecting pipe；
(9) 300 μ l AW2 washing lotions are added in adsorption column, 2min is placed, it is fully contacted with adsorption column,
12000rpm centrifuges 3min, changes clean collecting pipe；
(10) adsorption column lid is opened and places 2min, make that its inside and outside pressure is consistent, and 8000rpm skies are from 1min.It is empty from knot
Shu Yihou, repeat this step once.
(11) it is empty from end after, adsorption column is transferred in 1.5ml centrifuge tubes, open adsorption column lid, place 20-30min,
Make ethanol volatilization complete；
(12) 50 μ l Buffer AVE elution nucleic acid, 8000rpm centrifugation 1min, after centrifugation is completed, by under elution are added
Nucleic acid suck back adsorption column, lose adsorption column after centrifuging 1min.
3rd, the detection of actual clinical sample
1st, reaction system is prepared
15 μ l constant-temperature amplifications buffer solutions (see the step 11 of embodiment 1), 10 μ l constant-temperature amplifications enzyme solutions are taken (see the step of embodiment 1
Rapid 1 2), the clinical sample solution that 25 μ l step 2 are extracted to obtain is mixed into 50 μ l reaction solutions, is injected after vortex concussion uniformly
It is mounted with the 24 reaction chamber dish-style chips (see the step 13 of embodiment 1) of primer pair and ssDNA probe, seals rapid after membrana oralis
Centrifuge 30s.
2nd, isothermal amplification reactions and detection
Dish-style chip is placed in rich Isochip-RT constant-temperature amplifications instrument difficult to understand, sets 41 DEG C to react 1 hour, and complete simultaneously
Real-time fluorescence scans.And result is judged according to the method for the step 23 of embodiment 1.
Experiment sets reliability demonstration of the conventional RT-PCR method for kit testing result of the present invention simultaneously.For examining
The specific RT-PCR primer sequence for surveying each enterovirus is as shown in table 1.
Table 1 is used for the specific RT-PCR primer sequence for detecting 3 kinds of enteroviruses
| Index name | RT-PCR sense primers (5 ' -3 ') | RT-PCR anti-sense primers (5 ' -3 ') |
| Enterovirus | CCCCTGAATGCGGCTAATCCYAAC | CCAATCCAATAGCTATATGGYAACAA |
| Enterovirus EV 71 type | AACACCCGTAYGTGCTTGATGCTGG | TAGGGATTACTGGCGTCGCTCCTTG |
| Enterovirus CA16 types | CACCCCCATGCARCGCTTGTGYTTT | TRGACTGCCACGGRCCATCTCTTCC |
4th, result
The testing result of kit of the present invention is shown, for each enterovirus, is detected using RT-PCR method positive
Sample example using kit of the present invention detection show positive findings.Indicated above, kit of the present invention is to corresponding enteron aisle disease
The testing result of poison is accurately and reliably.The statistical result of kit and RT-PCR method of the present invention detection enterovirus clinical sample referring to
Table 2.
The statistical result of 2 kit of the present invention of table and RT-PCR methods detection enterovirus clinical sample
Claims (2)
1. the kit for detecting enterovirus, contains complete single stranded DNA；The complete single stranded DNA, by probe groups and primer
To a group composition；
The primer pair group, it is made up of following 3 primer pairs：As two single stranded DNAs shown in sequence in sequence table 1 and sequence 2
The primer pair 1 of molecular composition；The primer pair 2 being made up of two single strand dnas shown in sequence in sequence table 3 and sequence 4；By
Sequence 5 and the primer pair 3 of two single strand dnas composition shown in sequence 6 in sequence table；
The probe groups are made up of following 3 ssDNA probes：SsDNA probe 1 in sequence table shown in sequence 7；Sequence table
SsDNA probe 2 shown in middle sequence 8；SsDNA probe 3 in sequence table shown in sequence 9；
5 ' the ends mark of every ssDNA probe in the probe groups has FAM, and 3 ' ends mark has
Optical quenching group TAMRA；
The kit also contains internal reference primer pair and internal reference probe；The internal reference primer pair is by sequence in sequence table 10
With two single strand dnas composition shown in sequence 11；The internal reference probe is the single stranded DNA shown in sequence 12 in sequence table
Probe；5 ' ends of the internal reference probe are marked with fluorescent reporter group FAM, and 3 ' ends are marked with fluorescent quenching group TAMRA；
Also contain dish-style chip in the kit；
The 1# of the dish-style chip deposits dry as follows respectively to 6# reaction chambers（1）-（5）：
（1）The primer pair 1 and the ssDNA probe 1；
（2）The primer pair 2 and the ssDNA probe 2；
（3）The primer pair 3 and the ssDNA probe 3；
（4）The internal reference primer pair and the internal reference probe；
（5）Negative controls；
The dish-style chip is 24 reaction chamber dish-style chips.
2. kit according to claim 1, it is characterised in that：In the kit also containing constant-temperature amplification buffer solution and
Constant-temperature amplification enzyme solutions；
The solvent of the constant-temperature amplification buffer solution is water, and solute and concentration are as follows：200mM pH 8.0 Tris-HCL, 50mM
DTT, 10mM dNTP, 10mM rNTP, 80mM MgCl2, 450mM KCl, 15% volumn concentration DMSO, 1M sorbierite,
20mM tetramethyl ammonium chlorides；
The solvent of the constant-temperature amplification enzyme solutions is water, and solute and concentration are as follows：AMV reverse transcriptase 1U/ μ l, T7 RNA polymerize
Enzyme 5U/ μ l, ribonuclease H 0.5U/ μ l, the μ g/ μ l of pyrophosphatase 0.5U/ μ l, RNase inhibitor 5U/ μ l, BSA 0.5.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510479314.9A CN105112407B (en) | 2015-08-03 | 2015-08-03 | A kind of kit and its application for being used to detect enterovirus |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510479314.9A CN105112407B (en) | 2015-08-03 | 2015-08-03 | A kind of kit and its application for being used to detect enterovirus |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN105112407A CN105112407A (en) | 2015-12-02 |
| CN105112407B true CN105112407B (en) | 2018-01-09 |
Family
ID=54660521
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201510479314.9A Active CN105112407B (en) | 2015-08-03 | 2015-08-03 | A kind of kit and its application for being used to detect enterovirus |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN105112407B (en) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106435026B (en) * | 2016-10-13 | 2020-04-07 | 山东省疾病预防控制中心 | Primer group, probe and kit for detecting enterovirus |
| CN106521032B (en) * | 2016-11-30 | 2019-09-06 | 博奥生物集团有限公司 | A kind of nucleic acid amplification technologies and its application in carapuru virus detection |
| CN110055354B (en) * | 2019-04-23 | 2023-11-03 | 深圳市亚辉龙生物科技股份有限公司 | Nucleic acid composition, detection unit, microfluidic chip and detection device |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101545015A (en) * | 2009-05-11 | 2009-09-30 | 北京海康基因芯片开发有限公司 | Method for detecting infectious disease pathogens and kit |
| CN102676692A (en) * | 2011-12-08 | 2012-09-19 | 中国人民解放军军事医学科学院基础医学研究所 | Hand-foot-mouth disease virus EV71 nucleic acid detection kit |
| CN102732639A (en) * | 2011-04-11 | 2012-10-17 | 中国疾病预防控制中心病毒病预防控制所 | Application of GeXP multiplex gene expression genetic analysis system in hand-foot-and-mouth disease pathogenic typing and detection |
-
2015
- 2015-08-03 CN CN201510479314.9A patent/CN105112407B/en active Active
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101545015A (en) * | 2009-05-11 | 2009-09-30 | 北京海康基因芯片开发有限公司 | Method for detecting infectious disease pathogens and kit |
| CN102732639A (en) * | 2011-04-11 | 2012-10-17 | 中国疾病预防控制中心病毒病预防控制所 | Application of GeXP multiplex gene expression genetic analysis system in hand-foot-and-mouth disease pathogenic typing and detection |
| CN102676692A (en) * | 2011-12-08 | 2012-09-19 | 中国人民解放军军事医学科学院基础医学研究所 | Hand-foot-mouth disease virus EV71 nucleic acid detection kit |
Non-Patent Citations (3)
| Title |
|---|
| Development and evaluation of a nucleic acid sequence based amplification (NASBA) protocol for the detection of enterovirus RNA in cerebrospinal fluid samples;Albert Heim，Jens Schumann;《Journal of Virological Methods》;20021231;101-107 * |
| NASBA（依赖核酸序列的扩增）技术及其在病毒检测中的应用;高闪电 等;《中国生物工程杂志》;20091231;第29卷(第1期);80-85 * |
| 一种基于 NASBA 技术的新型快速肠道病毒检测方法的应用研究;唐震 等;《南京医科大学学报（自然科学版）》;20101231;第30卷(第12期);1729-1732 * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN105112407A (en) | 2015-12-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN105018648B (en) | A kind of kit and its application for being used to detect Respirovirus | |
| CN105112559B (en) | A kind of kit and its application for being used to detect coronavirus | |
| CN111020064B (en) | Novel coronavirus ORF1ab gene nucleic acid detection kit | |
| CN105039597B (en) | A kind of kit and its application for being used to detect influenza virus | |
| CN107513584B (en) | A kind of five heavy fluorescence quantitative kits detecting enterovirus | |
| CN105018488B (en) | Kit and its application for detecting Respirovirus | |
| US7247457B2 (en) | Detection and identification of enteroviruses by semi-nested amplification of the enterovirus VP1 protein | |
| CN103602757B (en) | The foundation of foot and mouth disease, vesicular stomatitis and swine pox multi-fluorescence RT-PCR detection method and application thereof | |
| CN107058623A (en) | A kind of High sensitivity and special blood HBV pgRNA fluorescence quantitative PCR detections systems and detection method | |
| CN111534637B (en) | Universal primer, probe and kit for enterovirus nucleic acid detection | |
| CN101942525B (en) | One-tube method with multiplex detection for human Influenza A and B and new Influenza A H1N1 virus and kit | |
| CN105112407B (en) | A kind of kit and its application for being used to detect enterovirus | |
| CN103388033B (en) | A kind of enterovirns type 71 (EV71) real-time fluorescence nucleic acid isothermal amplification detection kit | |
| CN110938709A (en) | Visual nucleic acid detection kit and method for enteroviruses based on recombinase polymerase amplification technology | |
| CN106086236A (en) | Detect test kit and the method for influenza virus H1, H3, H5, H7 simultaneously | |
| CN102367488B (en) | Enterovirus triple real-time fluorescent quantitative RT-PCR detection kit | |
| CN103966356A (en) | Human immunodeficiency virus type 1 one-step fluorescence quantitative RT-PCR detection kit | |
| CN105907890A (en) | Primers, probe and method for rapidly distinguishing HP-PRRS (High pathogenic porcine reproductive and respiratory syndrome) vaccine strain GDr180 from HP-PRRS wild strain | |
| CN105154584B (en) | A kind of the HRM non-marked detecting probe method and its primer and probe of quick differentiation PRRSV classical strains and variation strain | |
| Jokela et al. | Detection of human picornaviruses by multiplex reverse transcription-PCR and liquid hybridization | |
| CN108239676A (en) | A kind of parainfluenza virus one-step method fluorescence parting RT-PCR detection kit | |
| CN105039596B (en) | A kind of kit and its application for being used to detect parainfluenza virus | |
| Xia et al. | Rapid detection of Banna virus by reverse transcription-loop-mediated isothermal amplification (RT-LAMP) | |
| CN106868217A (en) | A kind of detection primer of zika virus and application | |
| CN103388032B (en) | A kind of coxsackie virus A 16-type (CA16) real-time fluorescence nucleic acid isothermal amplification detection kit |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| GR01 | Patent grant | ||
| GR01 | Patent grant |